Clinical characteristics | NCAPG | p-value |
---|
Low expression | High expression |
---|
Age (y) |
≥ 65 | 74 | 86 | 0.407 |
< 65 | 54 | 78 |
Sex |
Male | 63 | 87 | 0.556 |
Female | 65 | 77 |
Clinical stage |
I | 79 | 71 | 0.004 |
II | 28 | 44 |
III & IV | 21 | 49 |
T classification |
T1 | 47 | 41 | 0.091 |
T2 | 66 | 98 |
T3 & T4 | 15 | 25 |
N classification |
N0 | 92 | 92 | 0.006 |
N1 & N2 & N3 | 36 | 72 |
Metastasis |
No | 125 | 148 | 0.011 |
Yes | 3 | 16 |
- T for extent of the primary tumor; N for involvement of lymph nodes
- T1: Tumor ≤ 3 cm; T2: Tumor > 3 but ≤ 5 cm or tumor involving visceral pleura, main bronchus (not carina), atelectasis to hilum; T3: Tumor > 5 but ≤ 7 cm or invading chest wall, pericardium, phrenic nerve or or separate tumor nodule(s) in the same lobe; T4: Tumor > 7 cm or tumor invading: mediastinum, diaphragm, heart, great vessels, recurrent laryngeal nerve, carina, trachea, esophagus, spine or tumor nodule(s) in a different ipsilateral lobe
- N0: No regional node metastasis; N1: Metastasis in ipsilateral pulmonary or hilar nodes; N2: Metastasis in ipsilateral mediastinal/subcarinal nodes; N3: Metastasis in contralateral mediastinal/hilar, or suprclavicular nodes